Immunology

NASA flight surgeon Richard Scheuring monitors astronauts’ health before, during, and after their journeys into space. What he and others learn about space’s impact on health will help scientists develop novel treatments for people on Earth.

From microgravity to radiation, space wreaks havoc on astronauts’ immune systems, potentially putting them at risk of infection from microbes onboard.

Number of immunotherapy drugs in the drug development pipeline

Researchers plan to monitor the immune responses of COVID-19 patients for one year to see how they correlate with illness severity and lasting effects. This data will help develop personalized treatments for patients.

An upcoming clinical study will test whether a B. infantis probiotic can prevent the development of type 1 diabetes in predisposed infants.

Erica Ollman Saphire brings together scientific competitors to find new antibody therapeutics for COVID-19.

Bright Peak Therapeutics and Ajinomoto enter into research collaboration for novel immunocytokines

Asher Bio focuses on cis-targeting technology to precisely target discrete immune cell subtypes

First patient has been dosed in Phase 3 avatrombopag study for the treatment of ITP in children

Download this eBook from Drug Discovery News to learn about leading immunotherapy drugs in the pipeline and discover new approaches to immunotherapy drug discovery and delivery.